The US Patent and Trademark Office has granted a patent to Geneticure for its genetic test to predict response in renal denervation.

The US FDA has granted IDE approval for Dymicron to commence a pivotal trial of its Triadyme-C cervical artificial disc ...

Ablation therapy represents a significant innovation in cancer care. Advanced thermocouple wires are helping to deliver ...

Aqtual has secured $31m in a Series B financing round to launch a rheumatoid arthritis (RA) therapy response prediction test.

The UK's National Institute for Health and Care Excellence (NICE) has formally recommended the use of Pulsed Field Ablation (PFA) for the treatment of atrial fibrillation (AF) within the NHS.

Neuros Medical has raised $56m to support the US commercialisation of Altius direct electrical nerve stimulation system.

BVI is a winner in the Research and Development, Investments, and Product Launches categories in the 2025 Medical Device ...

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

MediView has announced the first patient enrolment in a study to assess the XR90 Holographic Surgical Navigation system.

Companion Spine has entered a definitive agreement to acquire Paradigm Spine’s business and assets from Xtant Medical Holdings.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Mendaera’s Focalist, a handheld robotic system.

Despite the threat of a 200% tariff, most pharma stocks remained stable. US President Donald Trump’s 200% tariff threat on the pharmaceutical industry is a “shock” that will reverberate through global ...